City

Philadelphia (2)

Pittsburgh (2)

Scottsdale (2)

Charleston (1)

Milwaukee (1)

Rochester (1)

San Diego (1)

Condition

Necrobiosis Lipoidica (3)

Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

phase 2 (3)

Sponsor

Processa Pharmaceuticals (2)

Aaron R. Mangold (1)

Collaborator

Intervention

pcs499 (2)

placebo (1)

ruxolitinib (1)

Study Documents

Intervention Type

drug (3)

other (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

necrobiosis lipoidica

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Necrobiosis Lipoidica Trial in United States (PCS499, )

Recruiting

Necrobiosis Lipoidica

PCS499
placebo

Scottsdale, Arizona
+6 more

Nov 1, 2022

Necrobiosis Lipoidica Trial in Philadelphia, Pittsburgh (PCS499)

Completed

Has Results

Necrobiosis Lipoidica

PCS499

Philadelphia, Pennsylvania
+1 more

Sep 1, 2022

Necrobiosis Lipoidica Trial in Scottsdale (Ruxolitinib)

Completed

Necrobiosis Lipoidica

Ruxolitinib

Scottsdale, Arizona

Mayo Clinic in Arizona

Mar 17, 2022